Vasculitis and Giant Cell Arteritis News

WASHINGTON — Alaska Native and American Indian populations demonstrate notably higher prevalences of ANCA-associated vasculitis vs. white patients, according to data presented at ACR Convergence 2024.

WASHINGTON — Upadacitinib 15 mg is superior to placebo for achieving sustained remission in giant cell arteritis across patient subgroups based on age, sex and glucocorticoid experience, according to data presented at ACR Convergence 2024.

Patients with severe Behçet’s syndrome who received infliximab demonstrated better odds of achieving complete response at 22 weeks compared with those who used cyclophosphamide, according to head-to-head data published in NEJM Evidence.

Patients with giant cell arteritis who use anticoagulants demonstrate lower risks for vision loss, stroke and other cranial ischemic complications, according to data published in Annals of the Rheumatic Diseases.

SAN DIEGO — Imaging techniques are poised to streamline the diagnosis of giant cell arteritis in the United States, after gaining traction elsewhere, according to a speaker at the 2024 Congress of Clinical Rheumatology West.

SAN DIEGO — Diagnosing giant cell arteritis and polymyalgia rheumatica can “fascinate” and cause “trepidation” in equal measure due to their similarities and complications, said a speaker at the 2024 Congress of Clinical Rheumatology West.

Tapering tocilizumab leads to a longer relapse-free period in patients with giant cell arteritis, compared with abrupt discontinuation, according to data published in Seminars in Arthritis and Rheumatism.

The European Medicines Agency Committee for Medicinal Products for Human Use has recommended the launch of proposed biosimilar rituximab candidate Ituxredi, Dr. Reddy’s Laboratories announced in a press release.

An growing therapeutic armamentarium for antineutrophil cytoplasmic antibody-associated vasculitis — including avacopan and azathioprine — is providing rheumatologists with an increasingly robust array of options, according to a presenter.